About us

Entopsis, the developers of PCRopsis™ nucleic acid extraction reagents, was founded in 2011 to reimagine research tools with impactful and low-cost solutions that approach problems from unconventional perspectives. We are predominantly focused in the areas of oncology and infectious diseases. Entopsis is proud to have established strategic academic and industry collaborations with renowned companies and institutions. We are greatly thankful for the support of Peter Thiel's Breakout Labs.